THERAPEUTIC VACCINATION METHOD, MUTATED PEPTIDES OF HIV REVERSE TRANSCRIPTASE AND THEIR USE FOR VACCINATION AND DIAGNOSTIC PURPOSES

Details for Australian Patent Application No. 2001290031 (hide)

Owner UNIVERSITE PIERRE ET MARIE CURIE - PARIS VI

Inventors KATLAMA, Christine; HAAS, Gaby; AUTRAN, Brigitte; SAMR I Assia; DEBRE, Patrice; CALVEZ, Vincent

Pub. Number AU-A-2001290031

PCT Pub. Number WO2003/025166

Filing date 14 September 2001

Wipo publication date 1 April 2003

International Classifications

C12N 009/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 039/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2001290031

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001290032

2001290030